Alzheimer's disease, the most common type of dementia, can be incredibly challenging for both the diagnosed individual and their loved ones. While current medical treatments are limited, alternative therapies and support resources are available.
Alzheimer's disease is the leading cause of dementia. It damages nerve cells in the brain and may not show many symptoms, especially in the early stages. Short-term memory loss is usually the first sign. As more neurons are damaged over time, reasoning, language, and thinking skills deteriorate. Eventually, the individual may lose the ability to perform daily functions and care for themselves.
Research into Alzheimer's disease focuses on ways to prevent or slow its progression. As we understand how the disease develops, so do intervention methods. Currently, there are a limited number of medical treatments available. For example, the drug Aduhelm (aducanumab), approved in June 2021, aims to reduce the accumulation of beta-amyloid protein plaques in the brain. These plaques disrupt normal nerve cell function, leading to disease progression. Treatment options and research continue; there is hope that a definitive cure may one day be found.
The Most Common Form of Dementia
Alzheimer's disease is the most common type of dementia. "Dementia" is a general term used to describe brain diseases characterized by memory loss and declining cognitive abilities. While Alzheimer's is the most common type, the following other types also exist:
• Vascular dementia
• Lewy body dementia
• Mixed dementia
• Dementia associated with Parkinson's disease
• Dementia due to Huntington's disease
According to 2022 data, more than 6,5 million people in the United States are living with Alzheimer's disease.
Alzheimer's Disease in Women
According to reports from the Alzheimer's Association, women are significantly more likely to develop Alzheimer's disease than men. Women have a 1 in 5 lifetime risk of developing Alzheimer's, while men have a 1 in 10 risk.
In the United States, approximately 4 million women and 2,5 million men live with Alzheimer's disease. Reasons for the higher rates in women include longer life expectancy and lower levels of formal education compared to men in the past. Lower levels of education are associated with an increased risk of Alzheimer's disease.
Furthermore, the disease appears to progress more rapidly in women. Women are generally diagnosed at later stages. This may be because women generally perform better than men on memory tests, and early symptoms can be overlooked.
Hormonal changes may also play a role. For example, there are studies suggesting a possible link between early menopause and Alzheimer's disease. Early hormone replacement therapy may have a brain-protective effect; however, research on this topic has not yet reached definitive conclusions.
Individuals who experienced hypertensive disorders during pregnancy (preeclampsia, eclampsia, HELLP syndrome) have shown greater brain shrinkage in later life. More research is needed to determine whether these disorders are a risk factor for Alzheimer's disease.
The Connection Between the Heart and the Brain
There is evidence that inflammation in one part of the body can affect other areas. In Alzheimer's disease, inflammatory proteins accumulate in the brain. Chronic diseases such as diabetes and heart disease are also known to be associated with inflammation.
Links have been found between heart disease, metabolic syndrome, diabetes, and Alzheimer's. According to a 2019 Circulation Research report, heart failure may trigger or worsen a brain disease such as Alzheimer's.
Here are some suggestions that may help prevent or slow down Alzheimer's:
• Mediterranean-type anti-inflammatory diet
• Regular monitoring of blood pressure and, if necessary, control with diet, exercise, or medication.
• If you smoke, you should quit.
• Regular physical activity
• Monitoring cholesterol levels
• Blood sugar control and diabetes management
In addition, cardiovascular diseases can affect the blood vessels that carry oxygen to the brain, increasing the risk of vascular dementia.
Education and Alzheimer's
Research shows that higher levels of education reduce the risk of Alzheimer's disease. Education contributes to a more resilient brain. Furthermore, higher levels of education are generally associated with higher income, which can improve living conditions and access to healthcare.
Suggestions for keeping the mind active:
• Starting a new course or hobby
• Learning a foreign language
• Playing a musical instrument
• Joining community groups and engaging in social interactions
Alzheimer's: A Leading Cause of Death
Alzheimer's disease is the sixth leading cause of death in the United States. One in three people over the age of 65 die from Alzheimer's or another form of dementia. According to the CDC, 121.499 people died from Alzheimer's in 2019. However, it's important to remember that while Alzheimer's isn't the direct cause of death, it can shorten life expectancy because it exacerbates other health problems.
Age, Demographics and Alzheimer's
Alzheimer's disease becomes more common with age:
• 65–74 years old: 5%
• 75–84 years old: 13,1%
• Over 85 years old: 33,2%
Furthermore, studies show that the disease is not evenly distributed among ethnic groups. In individuals over 65 years of age:
• Black Americans: 18,6%
• Hispanics: 14%
• Whites: 10%
These differences are thought to be related not to genetics, but to inequalities in access to healthcare, education, income level, and structural racism.
Economic Burden
In the U.S., treatment costs are rising due to the more than 6,5 million people living with Alzheimer's disease. Annual costs, estimated at approximately $236 billion in 2016, are projected to reach $321 billion in 2022. If this trend continues, costs could approach $1 trillion by 2050.
Discovery of the Disease
German physician Alois Alzheimer first described the disease in 1906 after examining a patient named Auguste D. who was experiencing memory loss. After the patient's death, shrinkage of brain tissue and abnormal protein accumulation were observed. In 1910, the disease was named Alzheimer's disease.
Loss of Sense of Smell
Changes in the sense of smell can be an early sign of Alzheimer's disease. However, these changes can also occur due to other causes such as Parkinson's disease, brain damage, or a sinus infection.
Life Expectancy
The life expectancy of a person diagnosed with Alzheimer's disease depends on many factors. While the average life expectancy is 4 to 8 years, some individuals live up to 20 years. Factors such as the stage of the disease, the person's overall health, and the quality of care all affect life expectancy.
Kaynaklar:
- FDA's Decision to Approve Aduhelm (2021)
- Alzheimer's Association. Alzheimer's Disease Facts and Figures (2022 and 2023)
- National Vital Statistics Reports: Deaths Final Data 2019
- Alzheimer's & Dementia. Economic & social burden of AD (2022)
- 2016 dementia care costs study
References
- Aduhelm (aducanumab) approval – June 2021
- The FDA approved Aduhelm (aducanumab) as a treatment for Alzheimer's disease with accelerated approval on June 7, 2021. newyorker.com+14pennmemorycenter.org+14secure.medicalletter.org+14sciencedirect.com+2drugs.com+2time.com+2.
- There are 6,5 million Alzheimer's patients (65 years and older) in the US.
- As of 2022, it is estimated that approximately 65 million people aged 6,5 and older in the United States are living with Alzheimer's dementia. alz.org+4cdc.gov+4mayoclinic.org+4.
- The lifetime risk of Alzheimer's disease is 1 in 5 for women and 1 in 10 for men.
- According to the Alzheimer's Association, the lifetime risk of Alzheimer's at age 45 is estimated to be 20% (1/5) for women and 10% (1/10) for men. alz.org+6alz.org+6pmc.ncbi.nlm.nih.gov+6.
- Nationwide distribution of patients by gender.
- In the United States, approximately 4 million women and 2,5–2,6 million men have Alzheimer's disease.
- In 2019, there were 121.499 Alzheimer's deaths (USA).
- According to CDC reports, 121.499 people died from Alzheimer's disease in 2019. cdc.gov+3pubmed.ncbi.nlm.nih.gov+3cdc.gov+3.
- Alzheimer's is the sixth leading cause of death in the United States.
- According to 2019 data, Alzheimer's disease is the sixth leading cause of death in the United States.
- Cost in 2016: $236 billion; estimate for 2022: $321 billion; ~$1 trillion by 2050.
- In 2016, dementia care cost the U.S. approximately $236 billion. pubmed.ncbi.nlm.nih.gov+1ajmc.com+1newyorker. com.
- This figure is estimated at $321 billion in 2022, and could reach $1 trillion by 2050.

